Tokyo, Japan

Kunihiko Takeyama



 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Newton, MA (US) (2006 - 2009)
  • Tokyo, JP (2015 - 2023)

Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kunihiko Takeyama: Innovator in Post-Transplant Lymphoproliferative Disorders

Introduction

Kunihiko Takeyama is a prominent inventor based in Tokyo, Japan, recognized for his significant contributions to the field of medical research. With a remarkable portfolio of five patents, he has made strides in the diagnosis and treatment of complex disorders. His innovative work primarily focuses on post-transplant lymphoproliferative disorders and hypoxia-associated angiogenesis disorders.

Latest Patents

Among Takeyama's latest innovations are compositions, kits, and methods designed for the diagnosis, prognosis, monitoring, treatment, and modulation of post-transplant lymphoproliferative disorders (PTLD) and hypoxia-associated angiogenesis disorders using galectin-1. His research demonstrates that galectin-1 (Gal1) plays a crucial role in viral-associated PTLD, specifically in cases linked to Epstein-Barr Virus (EBV). This groundbreaking invention opens new avenues for developing precise diagnostic and therapeutic strategies.

Career Highlights

Throughout his career, Takeyama has worked with renowned institutions, including Dana-Farber Cancer Institute and Brigham and Women's Hospital. His commitment to advancing medical science has established him as a leading figure in his field, influencing research protocols and treatment methodologies.

Collaborations

Takeyama has collaborated with notable professionals in the field, including Margaret A. Shipp and Jing Ouyang. These partnerships have played a pivotal role in enhancing the scope and impact of his research, contributing to innovative approaches in addressing challenging medical conditions.

Conclusion

Kunihiko Takeyama's innovative spirit and dedication to scientific exploration have resulted in significant advancements in the understanding and treatment of post-transplant lymphoproliferative disorders. As he continues to build upon his existing body of work, Takeyama remains a vital contributor to the medical research community, inspiring future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…